GSK's CEO Witty wants U.K. focus on manufacturing

GlaxoSmithKline ($GSK) CEO Andrew Witty (photo) said the U.K. needs to positively rebalance its economy, while growing the private sector with a focus on manufacturing, according to Social Enterprise. But trust in the private sector has eroded, he said, and business leaders have to lead by example in terms of corporate responsibility. Article

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.